Tudor Reilly Health: Specialists in online clinical trial recruitment and patient retention
Are EMRs the future of clinical trial recruitment?
eConsent comes of age
Industry warming to eConsent
21st Century Cures Act approved with overwhelming support
Market-specific considerations for clinical trial online advertising
Closing the gap between patients and pharma
Advertising clinical trials online. Why, How, What, Where? And what to avoid!
mHealth rides high but privacy concerns remain
Only a hip-hooray for HIPAA
Engaging the hard to reach
Clustering around patients
European data protection: the future
The Duchenne template for patient input
FDA guidelines called for to encourage use of new tech in clinical research
CROs capable partners in trial design?
The problem with outcome switching in clinical trials
Time to stop just talking about innovation
Getting a head start on cancer
Tudor Reilly Health discusses new European data protection laws in International Clinical Trials
Fighting fire with fire
All systems Go for Google
Digital information to the fore
Consumer tech showcase sets stage for inventive year in digital health
Tudor Reilly Health features in new book advocating for patient-driven R&D
Genetic find and replace
TEDMED goes back to basics
With a ‘post-antibiotic era’ looming-communication is key
Games aren’t just for fun
Tudor Reilly Health presents at Clinical Monitoring and Patient Recruitment & Retention Summit
A research tool in your pocket
Smart meds join the internet of things
Google’s biggest moon shot
Paradox of rare disease drug development
TRH to partner with The CATS Foundation
Honouring the code
BlackBerry’s lessons for Fitbit
Mary Meeker’s mobile internet trends
Pro bono support package with TRH
Rewards for good behaviour
Genomic portraits of two nations
Third time lucky
Tudor Reilly Health presents at 2nd Annual Operational Excellence in Clinical Trials Summit
Apple and the future of smartwatches
Ideate to innovate
Tudor Reilly Health presents at 7th Annual Patient Recruitment and Retention Summit
Why orphan approvals defy gravity
Genomics project to revolutionise medicine
Making clinical trials inclusive
Hepatitis C News reaches 65,000 unique visitors
Technology’s future in healthcare
Medical innovation, or recklessness?
Internet addiction: no longer a virtual reality?
Checking in with the brain’s GPS
Laughter in the courtroom!
TEDMED 2014 innovations empower patients
TEDMED 2014: Unlocking imagination in service of health and medicine
Digital privacy: are we sharing too much?
Should early-stage experimental drugs be used ahead of approval?
‘Appy as Larry
Healthy lifestyle advice – is it time for governments to butt out?
Tudor Reilly Health joins Britain’s most ambitious enterprises
Years in the making, social media guidance finally released
Costing lives – the promise and the price of new drug treatments
An elephant never forgets – but does the internet?
Digital tools provide insights into the rare
Why ownership is irrelevant in Pfizer bid for AstraZeneca
‘Vampire mice’ turn back the clocks
The direct-to-doctor app
How much is six months worth?
Controversy flares as Condoleezza Rice joins Dropbox board
Who’s afraid of Cochrane?
Big Pharma, Big Plans
Tudor Reilly Health supports Empower: Access to Medicine initiative
Personal information – public knowledge?
Tudor Reilly Health presents at Operational Excellence in Clinical Trials Summit
Nuts and bolts of digital patient recruitment
Tudor Reilly Health at the Clinical Outsourcing & Partnering World Conference 2014
Tudor Reilly Health moves to Tech City
Rare Disease Day 2014
Tapping the brain’s natural pharmacy
Troubled Twitter hopes for a brighter future
Facebook ad grab
Lean start-ups – build, test, adjust their way to success
Out in the cold – Big pharma and social media
New treatments set to awaken the sleeping pharmaceutical giants
Consumer Electronics Show 2014 – Wearing your heart (rate) on your sleeve
23andMe suspends health-related genetic tests
Big data: A challenge and an opportunity
Testing times for genome service 23andMe
The next generation: New technologies that could change the way we live
How big data can revolutionise patient recruitment to clinical trials
Indian ruling cuts hundreds of clinical trials
UK’s digital divide impacts upon the individual and the collective
Tudor Reilly Health in International Clinical Trials
Wanted: 100,000 volunteers to share their genetic information online
Google Plus aiming to revolutionise photography
Modern science must act against complacency
Tudor Reilly Health at the Festival of Marketing 2013
Walking could save 37,000 lives
Global digital privacy under the spotlight
Google’s Moon Shots
Tudor Reilly Health launches online patient forum for hepatitis C in partnership with HealthUnlocked
Life as an intern at Tudor Reilly Health
Doctors not so disconnected after all
Big Brother healthcare?
Tudor Reilly Health shortlisted for the Digital Impact Awards
Miniature brain opens research avenues
App-y ever after
Tudor Reilly Health – a top 25 health consultancy
Health and fitness apps make their mark as usage increases
Minding our language 2.0
Tudor Reilly Health a finalist at the PM Society Digital Media Awards
A digital union
Roundtable podcast – ePatient insights on hepatitis C
Perceptions of the patient
Tudor Reilly Health – a top 50 digital agency
Three-quarters of patients not told about clinical trials
Webcast roundtable: ePatient Insights on hepatitis C
Hold the fish: new study links fish oils to prostate cancer
Getting to grips with big data
The revolution will not be televised
Knights of healthcare
Catalysing open science
Google set to take a bite out of Apple
Tudor Reilly Health supports mental health awareness training for GP practices
Ireland to introduce plain cigarette packaging – triumph or disaster?
International Clinical Trials Day
Is there a gene for genius?
The Patient View?
H7N9 bird flu – the scientists are taking it seriously, but is anyone else?
Partnerships in Clinical Trials – Orlando
Unraveling our fascination with the double helix
Tudor Reilly Health MD shortlisted for the First Women Awards
The Wales Gene Park
Tudor Reilly in Florida
H1N1 data: a step towards transparency?
Reactions to job losses at AstraZeneca
Quis custodiet ipsos custodies?
Tudor Reilly Health roundtable at the Royal Society of Medicine
Delay preferable to error?
Pharma is cleaning up its act
Tudor Reilly Health roundtable at the Royal Society of Medicine
Bad Pharma – or Bad Regulators?
Leading public health official warns of viral apocalypse
Picking Pascal’s protégé
Stroke can hit at any age – Know the signs
Tudor Reilly Health wins international contract in biosimilars
Pharma predictions for 2013
Tudor Reilly’s highlights of 2012
Plotting the DNA map
Tudor Reilly rising star is one of PR Week’s 29 under 29
Clinical trial data – Free at last?
Escalating polypharmacy and the prescribing cascade
The future for mental illness and diagnosis
Clinical trial hotspots
The Hannah Crown Affair
World Mental Health Day
Light relief for the UK bioscience community
Mental health – the stigma that persists
BBC’s Jane Hughes speaks at Tudor Reilly Health roundtable
ZSL Stampede for AKU
The value of junk
We are all investors now
Minding our language
Failure a necessary part of Alzheimer’s success
Tudor Reilly announces healthcare heroes of the year
Olympic Twitter twits
Progress in hunt for Alzheimer’s cure
Tudor Reilly in PR Week’s Top 25 Healthcare Agencies
The medical social network
Playing catch-up: biosimilars policy struggles to stay ahead of the technological developments
Breast cancer mapped out
The Obesity Olympics?
Healthcare for all, not just the many
Glaxo and China: Yin and Yang?
United pledge to combat diseases of ‘neglected people’
Riddling Alzheimer’s disease
Tudor Reilly wins specialty pharmaceutical contract
Rare Treatments for Rare Diseases
AstraZeneca paves the way for UK research
Swap pills for health solutions
Tudor Reilly opens permanent London home
Pay-for-performance refunds – an ethical minefield?
Golden opportunity for the NHS to innovate
Drug relief for rare diseases
A UN talking shop or real action?
The Silly Season
Tudor Reilly leaps into PRWeek’s top 25 healthcare league table
Flipping back to the future: the power of the presenter
You’ve got mail
The end of the Prozac era or the start of something brainy from Roche?
The Final Frontier – negotiating the blood-brain barrier
The long and the short of a brave new world?
Given the oral clear
A gleam of light through the cloud of confusion
Learning from the heart
Apples and pears are crushed
Fortune favours the BRAF
Tudor Reilly achieves industry gold standard
What does the Pfizer closure really mean?
Joint win for Tudor Reilly and Red Health in sanofi-aventis UK diabetes pitch
The Risky Business of Reform
Chill forecast for Britain’s NHS in 2011
Increasing numbers of patients join online communities to Talk Health
An early Christmas present for big pharma
Tudor Reilly wins global internal communications contract
Alzheimer’s disease: The greatest medical challenge of our time?
Vending machines for medicines
Advances in Alzheimer’s research that promise to defeat dementia
Pharma’s drug pipeline still in trouble – but not everyone’s a loser
Partnering with patients in clinical trial design
Tudor Reilly leads rebranding of UK patient group
Finding a way through the UK clinical maze
Creating synthetic life
Difficult decisions in healthcare
Newron setback highlights vulnerability of biotech
Hard times for Britain’s health service
South Africa goes to war on HIV-AIDS
Personalised healthcare shows promise
Pharmaceutical industry leaders attend launch of D3
Breast cancer screening: The jury is out
Who pays for spin-outs?
Markets welcome healthcare reform
Social media lessons from Sanofi-Aventis
Alzheimer’s disease and the search for the silver bullet
Turning scientists into entrepreneurs
Scientists unlock the secret of ageing
How we age
Converting skin cells to working neurons
Obesity surgery on the NHS: The postcode problem
Tudor Reilly shortlisted for Buckinghamshire Enterprise Awards
The future of partnering
Tudor Reilly opens new London office
It’s JP Morgan time
Happy, healthy Christmas time…
Pharma looks to emerging markets to get ahead of the game
Spending on health where it matters
Industry stars honoured at Scrip Awards 2009
US praise for NHS
US comes close to healthcare reform
Hot off the press at Ausbiotech 2009
Is being healthy its own reward?
Lessons in motivation
Changing face of media
Make mine two GPs!
Tudor Reilly launches new website
An unacceptable conflict of interest?
Women to drive the future of the Economy?
Fighting the pharma flab
Tudor Reilly a PRide finalist
Stick to the rules
What next for Kennedy’s cause?
Are tweets just twittering?
Media silly season
Cashing in on swine flu
Tudor Reilly boosts senior team